IBRN Fees and Costs — iShares Neuroscience and Healthcare ETF
Data updated: 2026-10-13
The net expense ratio is 0.47%. There are no sales loads or redemption fees. In fiscal 2026 the fund paid $2K in broker commissions, 0.0390% of average net assets, and portfolio turnover was 52%.
IBRN Fees and Expenses
Annual operating expenses and sales charges of IBRN. Prospectus, as of July 31, 2025.
| Annual operating expenses | |
|---|---|
| Management fee | 0.47% |
| 12b-1 fee | 0.00% |
| Other expenses | 0.00% |
| Gross expense ratio | 0.47% |
| Fee waiver | — |
| Net expense ratio | 0.47% |
| Sales charges | |
|---|---|
| Max front load | — |
| Max deferred load | — |
| Redemption fee | — |
IBRN Costs Over Time
On $10,000 invested in IBRN, assuming 5% a year before costs, total costs come to $322 over 5 years, cutting the return by 0.53% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).
| $10,000 invested | Sell after 1 year | Sell after 3 years | Sell after 5 years |
|---|---|---|---|
| Value before costs | $10,500 | $11,576 | $12,763 |
| Fund expenses (net expense ratio 0.47%) | $49 | $155 | $270 |
| Trading costs (broker commissions) | $4 | $13 | $22 |
| Lost growth on money paid in costs | $0 | $8 | $29 |
| Total costs | $53 | $176 | $322 |
| Value after costs | $10,447 | $11,400 | $12,441 |
| Impact on return, per year | 0.53% | 0.53% | 0.53% |
IBRN Trading Costs
Brokerage costs reported on SEC Form N-CEN for the fiscal year ending July 31, 2026.
- Explicit cost rate (commissions ÷ average net assets): 0.0390%
- Total broker commissions: $2K
- Bought from dealers (principal trades, not a cost): $1.1M
- Portfolio turnover (prospectus): 52%
IBRN Agency Brokers
Commissions paid.
| Broker | Amount | Share |
|---|---|---|
| Cantor Fitzgerald & Co. | $526 | 32.53% |
| Goldman Sachs & Co. LLC | $191 | 11.79% |
| Cabrera Capital Markets LLC | $180 | 11.10% |
| BNP Paribas Securities Corp. | $171 | 10.58% |
| Barclays Capital Inc. | $150 | 9.26% |
| UBS Securities LLC | $107 | 6.63% |
| BofA Securities, Inc. | $88 | 5.42% |
| Samuel A. Ramirez & Company, Inc. | $85 | 5.27% |
| Cowen and Company, LLC | $66 | 4.05% |
| Virtu Americas LLC | $54 | 3.36% |
IBRN Dealer Counterparties
Securities bought directly from dealers (principal trades).
| Broker | Amount | Share |
|---|---|---|
| BlackRock Funds III - BlackRock Cash Funds: Treasury | $1.1M | 100.00% |
| BNP Paribas Securities Corp. | $47 | 0.00% |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.